InnovAge Holding Corp. Common Stock (INNV) is a publicly traded Healthcare sector company. As of May 21, 2026, INNV trades at $7.51 with a market cap of $984.09M and a P/E ratio of -93.06. INNV moved +4.30% today. Year to date, INNV is +37.04%; over the trailing twelve months it is +77.12%. Its 52-week range spans $2.60 to $10.69. Analyst consensus is sell with an average price target of $7.00. Rallies surfaces INNV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading INNV stock inside the company?
Recent INNV insider activity includes SCARBROUGH MICHAEL ANTHONY sold 33.00K, ZORETIC RICHARD C bought 8.45K, ZORETIC RICHARD C bought 14.27K, ZORETIC RICHARD C bought 20.00K, and ZORETIC RICHARD C bought 1.20K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
INNV Key Metrics
Key financial metrics for INNV
Metric
Value
Price
$7.51
Market Cap
$984.09M
P/E Ratio
-93.06
EPS
$-0.08
Dividend Yield
0.00%
52-Week High
$10.69
52-Week Low
$2.60
Volume
0
Avg Volume
0
Revenue (TTM)
$949.17M
Net Income
$-15.47M
Gross Margin
21.75%
Recent INNV Insider Trades
SCARBROUGH MICHAEL ANTHONY sold 33.00K (~$161.70K) on Nov 14, 2025.
ZORETIC RICHARD C bought 8.45K (~$34.48K) on May 30, 2025.
ZORETIC RICHARD C bought 14.27K (~$57.63K) on May 29, 2025.
ZORETIC RICHARD C bought 20.00K (~$81.20K) on May 28, 2025.
ZORETIC RICHARD C bought 1.20K (~$4.71K) on May 23, 2025.
Recent INNV insider activity includes SCARBROUGH MICHAEL ANTHONY sold 33.00K, ZORETIC RICHARD C bought 8.45K, ZORETIC RICHARD C bought 14.27K, ZORETIC RICHARD C bought 20.00K, and ZORETIC RICHARD C bought 1.20K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for INNV?
Yes. Rallies tracks INNV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is INNV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INNV. It does not provide personalized investment advice.